Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world

How we helped our client understand current and future combination pricing strategies in the Multiple Myeloma market

How we helped our client understand current and future combination pricing strategies in the Multiple Myeloma market

Our client had their product  for multiple myeloma (MM) approved in several lines of therapy combined with different backbones. Their product was also being studied in some other indications with additional backbones and was anticipated to receive approval in the coming years. With several other competitive therapies available on the market, including many branded combination products, our client anticipated that payers might start considering strategies to manage combination therapies in the future. Therefore, they wanted to understand what the current and future combination pricing strategies were for oncology products, with a focus on MM and their product.

read more »

How we helped assess the asthma market landscape in emerging markets

How we helped assess the asthma market landscape in emerging markets

Our client was jointly developing a fully-human monoclonal antibody (mAB) with a number of potential immunological indications. In order to prepare for launch, primary and secondary market research was required to understand more fully the asthma landscape.

read more »

How we assessed the access potential of a new product in order to develop a successful launch strategy

How we assessed the access potential of a new product in order to develop a successful launch strategy

Our client had two regimens in clinical development for the front-line treatment of an oncology condition using a breakthrough product; and planned to release outcomes data at key industry events throughout the year.

To ensure a fast and successful launch they wanted to develop key strategies to maximise acceptance and reimbursement of their product amongst HCPs and Payers. 

read more »

How we assessed payer perceptions of a new therapy for Atopic Dermatitis in emerging markets

How we assessed payer perceptions of a new therapy for Atopic Dermatitis in emerging markets

Our client was developing a product for use in treating a number of indications including Atopic Dermatitis (AD); and wanted to understand how best to position this product in order to optimise pricing and market access.

Market research was required to understand payer perceptions of the AD market, and the pricing and reimbursement opportunities in emerging markets.

read more »